Capital Flow Monitor · Sponsors · CIK 2008244
Entact Bio, Inc.
65 Grove Street, Suite 303, Watertown, MA, 02472 · 617-909-7579
Biotechnology · Corporation· inc. DELAWARE true 2021
Fit score
—
Offering
$10.0M
Sold
$10.0M
% sold
100.0%
Investors
7
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-06-03 | D ·current | 506(b) | $10.0M | $10.0M | 100.0% | 7 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Victoria Richon — Executive Officer / Director / Promoter, Watertown, MA
1 other raise
- Auron Therapeutics, Inc. $27.3M of $42.3M · 64.5%
- Owen Smith — Director, Watertown, MA
-
Pini Orbach — Director, Watertown, MA
1 other raise
- Auron Therapeutics, Inc. $27.3M of $42.3M · 64.5%
-
Andrew Sinclair — Director, Watertown, MA
8 other raises
- ML Pumping Up MI, LLC $2.7M of —
- Midloch Value Fund III, LLC $8.4M of $80.0M · 10.5%
- ML Rivertech, LLC $220K of $8.0M · 2.8%
- ML Fund III Capital Feeder, LLC $0 of $80.0M · 0.0%
- ML 94 Apartments Sidecar, LLC $10.7M of $10.7M · 100.0%
- ML Loyola Target, LLC $15K of $9.8M · 0.2%
- ML Moir Pref Two, LLC $0 of $8.0M · 0.0%
- ML PBR Apartments Sidecar, LLC $0 of $6.5M · 0.0%
-
Richard Gaster — Director, Watertown, MA
1 other raise
- Aeovian Pharmaceuticals, Inc. $55.0M of $55.0M · 100.0%
-
Anna French — Director, Watertown, MA
2 other raises
- Auron Therapeutics, Inc. $27.3M of $42.3M · 64.5%
- Renasant Bio, Inc. $30.0M of $30.0M · 100.0%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.